Post-surgery pancreatic cancer usually requires chemotherapy for 6-8 times, which takes about 6 months in total. There are more chemotherapy regimens, depending on the patient’s physical status, mFOLFIRINOX regimen, gemcitabine or capecitabine monotherapy, or gemcitabine combined with capecitabine regimen can be considered. Surgery for pancreatic cancer is relatively invasive, and different surgical methods are used depending on the site, which may be pancreaticoduodenectomy or pancreatic tail resection. Since the malignancy of pancreatic cancer tumor is relatively high, it is important to standardize the treatment after surgery, and at the same time, regular review in the hospital is necessary to prevent the tumor from recurrence, metastasis, or even complications after surgery.